Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
109 hedge funds and large institutions have $188M invested in Enzo Biochem, Inc. in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 32 reducing their positions, and 13 closing their positions.
55% more capital invested
Capital invested by funds: $121M → $188M (+$66.5M)
22% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 32
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
2% less funds holding
Funds holding: 111 → 109 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$2.07M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.4M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$1.26M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.13M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$943K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$4.45M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.08M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$892K |
| 4 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
-$740K |
| 5 |
Millennium Management
New York
|
-$567K |
ENZ Hedge Fund Activity: Q4 2016 in Review
109 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q4 2016, worth a combined $188M — up 55% from $121M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ENZ positions and 13 closed out — a net gain of 1 holder — while 39 added to existing stakes and 32 trimmed.
The largest buyer was Putnam Investments, opening a new position worth an estimated $2.07M. The largest seller was Granahan Investment Management, exiting entirely with an estimated $4.45M sold.
- 109 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q4 2016, down from 111 in Q3 2016.
- Funds reported $188M of Enzo Biochem, Inc. stock for Q4 2016, up 55% quarter-over-quarter.
- 14 funds opened new Enzo Biochem, Inc. positions in Q4 2016 and 13 closed out, a net change of +1 holder.
- The largest Enzo Biochem, Inc. buyer in Q4 2016 was Putnam Investments, an estimated $2.07M added.
- The largest Enzo Biochem, Inc. seller in Q4 2016 was Granahan Investment Management, an estimated $4.45M sold.
Based on aggregated 13F filings for Q4 2016.